Overall rank by patents
#44,721
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23K (Fodder).
The verdict
According to USPTO PatentsView, Anitox ranks #44,721 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R44721 · US Corporation #44,721 · 5 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Anchored Rsk3 Inhibitors, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Innovative Music · near
22 score
Micro*D · near
22 score
BBS Motorsport · near
22 score
Anitox · this assignee
22 score
Amano Enzyme U · near
22 score
3D Lighting… · lowest
7 score
What this shows Anitox's Innovation Score is 22.3/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Anitox Corporation is a focused PatentsView assignee: 7 CPC subclasses with 80% of grants classified under A23K (Fodder). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2018. By volume, Anitox sits between Anchored Rsk3 Inhibitors, LLC and Anker Technology Co., Limited.
Anitox Corporation shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Anchored Rsk3 Inhibitors, LLC
5 patents
Andritz S.A.S.
5 patents
Anhui New Star Pharmaceutical Development Co., Ltd
5 patents
Animoto Inc.
5 patents
Aniya's Production Company
5 patents
Anji Microelectronics (Shanghai) Co. Ltd
5 patents
Anji Younike Furniture Co., Ltd.
5 patents
Anker Technology Co., Limited
5 patents
Anitox Corporation
5 patents
What this shows Anitox holds 5 patents at rank #44,881, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #44,881 in granted patent volume.
Other assignees with the most granted patents in Anitox's primary technology class.
Two PlainPatent-derived peer sets for Anitox, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (22 here).
Anitox's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
22 10th percentile higher than 10% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2020 | 2 | 40.0% |
| 2021 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Top 7 of 7 technology areas
Overall rank by patents
#44,721
of 49,997 tracked assignees
22.3 out of 100
What to do with this data
Anitox Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.